Oriza Holdings
元禾控股
elsewhere's corpus does not cover Oriza Holdings as a subject. The only retrieved mention is a single investment relation showing it participated in a 2022 Shize Biotech funding round led by Qiming Venture Partners, Lilly Asia Ventures and others . No entity card, profile or strategy description is available in the bundle.
AI-generated — may contain errors, please verify.
Oriza HoldingsFund
元禾控股
渲染中…
Mentioned in 4 articles
Coverage
BlueRun Ventures Portfolio Company Puyu Technology Closes Hundreds of Millions of RMB Financing to Accelerate Nanoimprint Lithography Equipment Commercialization | BlueRun Family
Opening a New Front for China's Semiconductor Breakthrough
Breaking Into Silicon Valley, David Wei Blazes a New Trail for Dollar Funds | Getting in the Game
"There's no way to stop the exchange of ideas between people."
Heading Into the Next Spring Amid Winter: 7 Early-Stage Companies Raise Nearly 600 Million RMB | FreeS Family Funding News · Vol 13
Looking forward to working alongside more outstanding founders.
Two Decades of RMB Funds: Between Life and Death
Are USD Funds in Trouble? Is It the RMB Funds' Turn to Make a Move?
